Back to Markets
MOMolecular Partners AG

Molecular Partners AG

MOLN
Health CareBiotechnology: Biological Products (No Diagnostic Substances)

$4.16

+0.1600 (+3.93%)

As of 05/29/26 EDT · USD

Compare
Low: $3.41Current: $4.16High: $5.36

Key Statistics

Open

$4.11

Day High

$4.20

Day Low

$4.11

Prev. Close

$4.00

VolumeShares traded today.

1.19K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$167.96M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.14

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$5.36

52W LowLowest price over the past 52 weeks.

$3.41

50D MAAverage closing price over the last 50 trading days.

$4.17

200D MAAverage closing price over the last 200 trading days.

$4.15

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

+10.5%

1M

-5.6%

6M

+5.0%

YTD

-0.5%

1Y

+10.8%

About

Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.

Company Facts

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade MOLN

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.